Citigroup’s DarioHealth DRIO Stock Holding History

Citigroup’s Portfolio DRIO Stock Details DRIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1	Closed	-$8	–	5852
2026 Q1	$8	Buy	+1	New	+$10	﹤0.01%	5749
2023 Q3	–	Sell	-8	Closed	-$654	–	5703
2023 Q2	$654	Hold	8	–	–	﹤0.01%	5361
2023 Q1	$672	Hold	8	–	–	﹤0.01%	5182
2022 Q4	$698	Hold	8	–	–	﹤0.01%	5462
2022 Q3	$1K	Sell	8 -7	-47%	-$751	﹤0.01%	5622
2022 Q2	$2K	Sell	15 -22	-59%	-$2.58K	﹤0.01%	5874
2022 Q1	$4K	Sell	37 -1,391	-97%	-$230K	﹤0.01%	5882
2021 Q4	$370K	Buy	1,428 +1,343	+1,580%	+$408K	﹤0.01%	3992
2021 Q3	$23K	Buy	85 +48	+130%	+$13.8K	﹤0.01%	5167
2021 Q2	$16K	Buy	+37	New	+$14.1K	﹤0.01%	5418

Other funds holding DRIO

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Global Advisers Malvern, Pennsylvania $215B AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Citigroup's DRIO Position: Q2 2026 in Review

Citigroup sold out of DarioHealth (DRIO) in Q2 2026, closing a stake of 1 share — an estimated $8 sold.

Citigroup first reported a position in DRIO in Q2 2021 and held it in 10 quarters. The position peaked at $370K in Q4 2021. 21 funds tracked by Wall St. Rank hold DRIO as of Q2 2026.

Citigroup reported no remaining DarioHealth position as of Q2 2026 after selling out during the quarter.
Citigroup sold 1 DarioHealth share in Q2 2026, an estimated $8.
Citigroup first reported a position in DarioHealth in Q2 2021 and held it in 10 quarters.
Citigroup's DarioHealth position peaked at $370K in Q4 2021.
21 funds tracked by Wall St. Rank held DarioHealth as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.